Several reports and studies have linked pre-natal exposure to Zofran to hypospadias, a urethral abnormality that affects baby boys. A growing number of Zofran lawsuit filings claim that the drug’s manufacturer concealed its association with this and other birth defects.
Bernstein Liebhard LLP is now offer free legal reviews to families throughout the U.S. whose child may have been born with a Zofran-related birth defect. If your baby boy was diagnosed with hypospadias, and his mother was treated with Zofran in the first trimester of pregnancy, please call (888) 994-5118 to learn more about your legal rights.
Hypospadias is a congenital abnormality in which the opening of the urethra is not located at the tip of the penis. Hypospadias may occur as one of three types:
It is estimated that each year about 5 of every 1,000 infant boys born in the U.S. have hypospadias.
The cause of hypospadias is not known. However, some risk factors have been identified:
Children with untreated hypospadias may have difficulty learning how to go to the toilet properly. In adulthood, they may experience issues with sexual function. In most cases, a boy with hypospadias will undergo surgery to correct the defect between the ages of ages of 3–18 months. Sometimes, the surgery will take place in stages. Because the foreskin might be needed to correct the defect, a baby boy with hypospadias should not be circumcised.
The urethra develops during the first trimester of gestation. Millions of expectant mothers have been prescribed Zofran during this same time period to treat nausea and vomiting associated with pregnancy. Recently, reports have suggested that use of Zofran in the first trimester increases the risk that a baby will be born with a major birth defect, including hypospadias.
More and more families are filing Zofran lawsuits on behalf of children who allegedly suffered birth defects following first-trimester exposure to the drug. These plaintiffs claim that GlaxoSmithKline received numerous reports of birth defects potentially associated with Zofran, but withheld this information from the public and medical community. The company is also accused of aggressively marketing Zofran as an appropriate treatment for morning sickness, even thought the medication has never been approved for this purposes. Read More
October 2015: Dozens of Zofran lawsuits have been centralized in the U.S. District Court, District of Massachusetts, for the purposes of coordinated pretrial proceedings. By November 2015, more than 100 such cases had been filed in the proceeding. Read More
You may be able to file a Zofran lawsuit if your child was born with hypospadias following pre-natal exposure to the anti-nausea drug. To learn if you qualify, please contact Bernstein Liebhard LLP today by calling (888) 994-5118.
Get the latest news and litigation updates about this case by following us on Facebook. Click the "Like" button below.